SMARCA1 and gastric cancer: Endometrial cancer, gallbladder and biliary tract cancer, and gastric cancer exhibit particularly high rates of SWI/SNF mutations, with frequencies of 54.1%, 43.4%, and 33.9%, respectively [27].